Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
July 25, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
All Press Releases for March 21, 2008 Subscribe to this News Feed      
 

Possible Trasylol Insiders Should Contact Americas Watchdog Immediately

Americas Watchdog is one of the premier consumer advocacy groups in the United States. Because of numerous horror story's in the national press, about the drug called Trasylol, Americas Watchdog has initiated a national investigation focused on this drug. The primary goal of this investigation is to obtain information from the potential victims and or their families. The second aspect of this investigation is to encourage members in the health care community to tell Americas Watchdog what they know about this drug and its use in surgical procedures

(PRWEB) March 21, 2008 -- Americas Watchdog and its Corporate Whistle Blower Center have initiated a national investigation involving the drug called Trasylol. If a possible victim, or a family member of a possible Trasylol victim, has knowledge of severe side affects related to exposure to this drug, they should contact Americas Watchdog immediately at 866-714-6466. Trasylol is manufactured by the pharmaceutical drug giant Bayer.

According to the network TV new program 60 Minutes, the use of Trasylol may be linked to over 20,000 US deaths. According to the 60 Minutes report, "Bayer withheld critical clinical information from the US FDA. Had this information been available to the U.S. Food and Drug Administration, the drug would could have been recalled."

According to news accounts, the drug maker Bayer knew of issues with Trasylol as far back as 2002, yet they continued to allow the drug to be used in heart related surgical procedures. According to Americas Watchdog, "If true, this is an outrage that may have cost thousands and thousands of Americans their lives."

Americas Watchdog thinks that possible victims or loved ones of the Bayer drug called Trasylol need to know the truth. According to the group, "we will do our best to help every victim or family member of a victim discover what actually happened, and our group will also help the victim or the victims family get a legal assessment as to what their legal rights may be."

Here is what Americas Watchdog has discovered so far about Trasylol:
Trasylol was given to patients undergoing heart procedures. At one point Trasylol may have been given to as many as 1/3rd of all US patients undergoing a surgical heart procedure.

Traslol has been linked to kidney failure and other severe side affects.
One dose of Trasylol may have cost $1000 or more, even though there were generic drugs available at $10 per dose with no reported side affects.

According to Americas Watchdog, there is no way that physicians or hospitals could not have known about these risks in 2006, or 2007. Americas Watchdog has put a Trasylol web page on its current initiatives site http://AmericasWatchdog.com. Individuals or family members of possible victims who were exposed to Trasylol should contact Americas Watchdog immediately at 866-714-6466. Medical professionals or physicians with specific information about Trasylol should contact Americas Watchdog immediately at 866-714-6466.

Americas Watchdog is one of the premier advocacy groups in the United States. The group is all about consumer protection and corporate responsibility.

###

OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
Email this story to a colleague
CONTACT INFORMATION
THOMAS MARTIN
Americas Watchdog
866-714-6466
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright